Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$174.13NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/19/19

Today's Change-3.96(2.22%)
Bid (Size)$165.00 (383)
Ask (Size)$179.00 (2)
Day Low / High$174.05 - 179.15
Volume1.1 M

View Biotechnology IndustryPeer Comparison as of 07/19/2019


Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $174.13
Change: -3.96 (2.22%)
Volume: 1.1 M
4:00PM ET 7/19/2019

Biogen Inc ( NASDAQ )

Price: $231.27
Change: -0.96 (0.41%)
Volume: 1.3 M
4:15PM ET 7/19/2019

Illumina Inc ( NASDAQ )

Price: $293.20
Change: -5.35 (1.79%)
Volume: 1.7 M
4:00PM ET 7/19/2019

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $298.11
Change: -4.98 (1.64%)
Volume: 692.7 K
4:00PM ET 7/19/2019

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $120.80
Change: -2.46 (2.00%)
Volume: 1.5 M
4:00PM ET 7/19/2019

Read more news Recent News

Sector Update: Health Care Stocks End on Positive Ground
4:07PM ET 6/21/2019 MT Newswires

Top Health Care Stocks JNJ -0.05% PFE +0.87% ABT +0.16% MRK 0.00% AMGN +0.84% Health care stocks closed moderately higher this afternoon, turning...

Sector Update: Health Care
3:55PM ET 6/21/2019 MT Newswires

Health care stocks were moderately higher this afternoon, turning around their prior declines. At last look, the NYSE Health Care Index was rising almost...

FDA Clears Vertex Pharma's Cymdeko for Cystic Fibrosis Patients Ages 6 Years and Older
2:48PM ET 6/21/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) was narrowly higher this afternoon, reversing a nearly 1% decline earlier Friday, after the US Food and Drug Administration...

Sector Update: Biotechs Lift Health Care Stocks to Large Gain
3:55PM ET 6/07/2019 MT Newswires

Top Health Care Stocks JNJ +1.70% PFE +0.80% ABT +1.07% MRK +1.38% AMGN +0.67% Health care stocks were ending near their session highs, with the NYSE...

View all Commentary and Analysis

Vertex Pharmaceuticals: A Stock That Continues To Impress In 2019
3:05PM ET 7/01/2019 Seeking Alpha

Vertex Pharmaceuticals Is A Good Long-Term Investment
1:31PM ET 6/26/2019 Seeking Alpha

Vertex Makes Strong Push Into Crispr Tech With 2 Deals At Once
4:31PM ET 6/17/2019 Seeking Alpha

BIIB Is For Buy-O-Gen
10:30AM ET 6/12/2019 Seeking Alpha

Company Profile

Business DescriptionVertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. View company web site for more details
Address50 Northern Avenue
Boston, Massachusetts 02210
Number of Employees2,500
Recent SEC Filing07/17/20194
Chairman, President & Chief Executive OfficerJeffrey M. Leiden
Chief Financial Officer & Executive Vice PresidentCharles F. Wagner
Chief Scientific Officer & EVP-Global ResearchDavid Matthew Altshuler
Chief Medical Officer & Executive Vice PresidentReshma Kewalramani

Company Highlights

Price Open$179.15
Previous Close$178.09
52 Week Range$151.80 - 195.81
Market Capitalization$44.6 B
Shares Outstanding256.1 M
SectorHealth Technology
Next Earnings Announcement07/31/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings20.98
Earnings per Share$8.37
Beta vs. S&P 500N/A
Revenue$3.0 B
Net Profit Margin66.24%
Return on Equity58.43%

Analyst Ratings as of 07/12/2019

Consensus RecommendationConsensus Icon
Powered by Factset